352 related articles for article (PubMed ID: 26330077)
1. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.
Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077
[TBL] [Abstract][Full Text] [Related]
2. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.
Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N
Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916
[TBL] [Abstract][Full Text] [Related]
3. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
[TBL] [Abstract][Full Text] [Related]
4. Discovery of pyrrolospirooxindole derivatives as novel cyclin dependent kinase 4 (CDK4) inhibitors by catalyst-free, green approach.
Kamal A; Mahesh R; Nayak VL; Babu KS; Kumar GB; Shaik AB; Kapure JS; Alarifi A
Eur J Med Chem; 2016 Jan; 108():476-485. PubMed ID: 26708114
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3'-methoxy-4'-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents.
Senwar KR; Reddy TS; Thummuri D; Sharma P; Naidu VG; Srinivasulu G; Shankaraiah N
Eur J Med Chem; 2016 Aug; 118():34-46. PubMed ID: 27128173
[TBL] [Abstract][Full Text] [Related]
6. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
7. Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents.
Dweedar HE; Mahrous H; Ibrahim HS; Abdel-Aziz HA
Eur J Med Chem; 2014 May; 78():275-80. PubMed ID: 24686014
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents.
Ramanivas T; Sushma B; Nayak VL; Chandra Shekar K; Srivastava AK
Eur J Med Chem; 2015 Mar; 92():608-18. PubMed ID: 25615796
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
Yugandhar D; Nayak VL; Archana S; Shekar KC; Srivastava AK
Eur J Med Chem; 2015 Aug; 101():348-57. PubMed ID: 26163220
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y
Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds.
Zhou A; Yan L; Lai F; Chen X; Goto M; Lee KH; Xiao Z
Bioorg Med Chem Lett; 2017 Aug; 27(15):3326-3331. PubMed ID: 28625363
[TBL] [Abstract][Full Text] [Related]
17. Facile synthesis of simple 2-oxindole-based compounds with promising antiproliferative activity.
George RF
Future Med Chem; 2018 Feb; 10(3):269-282. PubMed ID: 29334243
[TBL] [Abstract][Full Text] [Related]
18. The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.
Sampson PB; Liu Y; Patel NK; Feher M; Forrest B; Li SW; Edwards L; Laufer R; Lang Y; Ban F; Awrey DE; Mao G; Plotnikova O; Leung G; Hodgson R; Mason JM; Wei X; Kiarash R; Green E; Qiu W; Chirgadze NY; Mak TW; Pan G; Pauls HW
J Med Chem; 2015 Jan; 58(1):130-46. PubMed ID: 24867403
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of ring-C modified oleanolic acid derivatives and their cytotoxic evaluation.
Pattnaik B; Lakshma Nayak V; Ramakrishna S; Venkata Mallavadhani U
Bioorg Chem; 2016 Oct; 68():152-8. PubMed ID: 27522460
[TBL] [Abstract][Full Text] [Related]
20. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]